Subsequent research could then focus on the establishment of more targeted and individual treatment strategies in this subgroup, as previously shown for Her2/neu expression and trastuzumab treatment in breast cancer (Pegram et al, 2000). The gene discussed is ERBB2; the disease is breast carcinoma.